Combination intravitreal rituximab and methotrexate for massive subretinal lymphoma
Authors:
- 13 August 2010
- journal article
- other
- Published by Springer Nature in Eye
- Vol. 24 (10) , 1625-1627
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Effect of Intravitreous Rituximab Injections in Patients With Recurrent Ocular Lesions Associated With Central Nervous System LymphomaJAMA Ophthalmology, 2008
- Primary lymphoma of the central nervous system: epidemiology, pathology and current approaches to diagnosis, prognosis and treatmentLeukemia & Lymphoma, 2008
- Intraocular use of rituximabEye, 2007
- International Central Nervous System and Ocular Lymphoma Workshop: Recommendations for the FutureOcular Immunology and Inflammation, 2006
- Intraocular lymphomaCurrent Opinion in Ophthalmology, 2002
- Role of intravitreal methotrexate in the management of primary central nervous system lymphoma with ocular involvementHistorical imageOphthalmology, 2002